Literature DB >> 19494822

Hepatitis C: new therapeutic strategies needed for advanced disease.

Wolf P Hofmann, Stefan Zeuzem.   

Abstract

Mesh：

Substances：

Year:  2009        PMID： 19494822     DOI： 10.1038/nrgastro.2009.63

Source DB:  PubMed          Journal:  Nat Rev Gastroenterol Hepatol        ISSN： 1759-5045            Impact factor:   46.802


× No keyword cloud information.
  8 in total

1.  Effect of interferon therapy on the development of hepatocellular carcinoma in patients with hepatitis C virus-related cirrhosis: a meta-analysis.

Authors:  G V Papatheodoridis; V C Papadimitropoulos; S J Hadziyannis
Journal:  Aliment Pharmacol Ther       Date:  2001-05       Impact factor: 8.171

Review 2.  Interferon-based therapy for chronic hepatitis C: current and future perspectives.

Authors:  Stefan Zeuzem
Journal:  Nat Clin Pract Gastroenterol Hepatol       Date:  2008-10-07

3.  Impact of pegylated interferon alfa-2b and ribavirin on liver fibrosis in patients with chronic hepatitis C.

Authors:  Thierry Poynard; John McHutchison; Michael Manns; Christian Trepo; Karen Lindsay; Zachary Goodman; Mei-Hsiu Ling; Janice Albrecht
Journal:  Gastroenterology       Date:  2002-05       Impact factor: 22.682

4.  Interferon and prevention of hepatocellular carcinoma in viral cirrhosis: an evidence-based approach.

Authors:  C Cammà; M Giunta; P Andreone; A Craxì
Journal:  J Hepatol       Date:  2001-04       Impact factor: 25.083

5.  Herbal product use by persons enrolled in the hepatitis C Antiviral Long-Term Treatment Against Cirrhosis (HALT-C) Trial.

Authors:  Leonard B Seeff; Teresa M Curto; Gyongyi Szabo; Gregory T Everson; Herbert L Bonkovsky; Jules L Dienstag; Mitchell L Shiffman; Karen L Lindsay; Anna S F Lok; Adrian M Di Bisceglie; William M Lee; Marc G Ghany
Journal:  Hepatology       Date:  2008-02       Impact factor: 17.425

6.  Prolonged therapy of advanced chronic hepatitis C with low-dose peginterferon.

Authors:  Adrian M Di Bisceglie; Mitchell L Shiffman; Gregory T Everson; Karen L Lindsay; James E Everhart; Elizabeth C Wright; William M Lee; Anna S Lok; Herbert L Bonkovsky; Timothy R Morgan; Marc G Ghany; Chihiro Morishima; Kristin K Snow; Jules L Dienstag
Journal:  N Engl J Med       Date:  2008-12-04       Impact factor: 91.245

7.  Sustained virologic response and clinical outcomes in patients with chronic hepatitis C and advanced fibrosis.

Authors:  Bart J Veldt; E Jenny Heathcote; Heiner Wedemeyer; Juerg Reichen; W Peter Hofmann; Stefan Zeuzem; Michael P Manns; Bettina E Hansen; Solko W Schalm; Harry L A Janssen
Journal:  Ann Intern Med       Date:  2007-11-20       Impact factor: 25.391

8.  Brief communication: the relationship of regression of cirrhosis to outcome in chronic hepatitis C.

Authors:  Vincent Mallet; Hélène Gilgenkrantz; Jeanne Serpaggi; Virginie Verkarre; Anaïs Vallet-Pichard; Hélène Fontaine; Stanislas Pol
Journal:  Ann Intern Med       Date:  2008-09-16       Impact factor: 25.391
  8 in total
  1 in total

Review 1.  Antiviral therapy of chronic hepatitis C in patients with advanced liver disease and after liver transplantation.

Authors:  Jan Peveling-Oberhag; Stefan Zeuzem; Wolf Peter Hofmann
Journal:  Med Microbiol Immunol       Date:  2009-11-10       Impact factor: 3.402
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.